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Amoxicillin prophylaxis against experimental endocarditis due to one nontolerant and
two tolerant strains of streptococci was studied in rats. Single-dose amoxicillin pro-
tected against the two tolerant strains in animals challenged with the 90% infective dose
(ID9o), but protection diminished with increasing inoculum sizes. Protection against the
nontolerant strain was successful with inocula that were 100-and I,OOO-fold larger than
the 1D90. Close correlation existed between the speed of bacterial killing in vitro, the time
of exposure to bactericidal levels in vivo, and the range of inocula against which pro-
phylaxis was effective. Amoxicillin seemed to protect by at least two mechanisms. (1)
When in vitro tests indicated adequate bacterial killing, protection was independent of
the inoculum size and was probably conferred by bacterial killing. (2) When in vitro
tests indicated bacterial inhibition but not. killing, protection was inoculum-dependent
and was probably mediated by inhibition of bacterial adherence.
Preexisting endothelial cardiac lesions may be col-
onized during bacteremia, resulting in bacterial
endocarditis. It has been recommended that pa-
tients with known cardiac lesions receive prophy-
lactic antibiotics before undergoing procedures
that might cause bacteremia [1, 2]. Because clini-
cal trials of antibiotic prophylaxis in humans can-
not be conducted for both ethical and statistical
reasons [3], the question of which antibiotic and
what dosage to use has been studied mainly in ani-
mals. The rabbit model developed by Garrison
and Freedman [4] was used to test several prophy-
lactic antibiotic regimens. These experiments sug-
gested that bactericidal antibiotics would have to
be given to obtain adequate prophylaxis and that a
synergistic combination of antibiotics would be
more effective than a single agent [5]. In rabbits,
parenteral penicillin and vancomycin have been
shown to be effective in preventing bacterial endo-
carditis. However, some strains of viridans strep-
tococci are relatively resistant to the bactericidal
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activity of penicillin [6]. Indeed, when we mea-
sured the sensitivity to amoxicillin, (a well-ab-
sorbed penicillin advocated for prophylaxis in hu-
mans [7]) and to vancomycin (the most powerful
prophylactic agent in rabbits) of streptococci iso-
lated from patients with endocarditis, we found
that eight of 21 strains were tolerant to amoxicillin
(MBC:MIC ratio, >32 [8]) and that five of 20 were
tolerant to vancomycin.' Therefore, prophylaxis
against endocarditis by means of bacterial killing
would have failed against these strains. However,
in recent experiments using a rat model, we showed
that vancomycin prevented endocarditis in the ab-
sence of bacterial killing [9]. Because amoxicillin
is easier to administer than vancomycin, we inves-
tigated amoxicillin prophylaxis against experimen-
tal endocarditis caused by strains of streptococci
that are variously sensitive to the bactericidal ac-
tivity of amoxicillin.
Materials and Methods
Microorganisms. Three bacterial strains were
used to produce endocarditis. (1) Streptococcus
intermedius, also called Streptococcus sanguis [9],
1 M. P. Glauser, P. Meylon, P. Francioli, and P. Moreillon,
"Tolerance to Amoxicillin and Vancomycin among Strains of
Non-Group 0 a-Hemolytic Streptococci Isolated from Pa-
tients with Endocarditis," manuscript in preparation.
Mechanisms ofEndocarditis Prophylaxis
was originally isolated from a patient with endo-
carditis. This strain has been used in experiments
on endocarditis in both rabbits [10] and rats [9,
11]. (2) S. sanguis biotype II was provided by Dr.
D. T. Durack (Duke University Medical Center,
Durham, N.C.) who had used it in his investiga-
tions of prophylaxis against endocarditis in rab-
bits [5, 12]. (3) Streptococcus mitior was isolated
from a patient in Lausanne with endocarditis. It
was chosen because, of 23 strains of a-hemolytic
streptococci isolated from patients with endocardi-
tis, it was the most sensitive to the bactericidal ac-
tion of amoxicillin.'
Determination of MICs, MBCs, and rates of
bactericidal activity. The MICs of amoxicillin
and vancomycin were determined with a standard
broth dilution technique [13] with an inoculum of
105-106 organisms from either an overnight or a
log-phase culture. The MBCs were determined by
subculturing on penicillinase-containing blood
agar plates 0.1 ml of an undiluted sample, as well
as 0.1 ml each of 10-fold and lOO-fold dilutions,
from each dilution of antibiotic showing no tur-
bidity after 24 hr and 48 hr of incubation. After
incubation for 48 hr, the number of colonies on
each plate was counted, and the MBC was deter-
mined as the lowest dilution of .antibiotic that
showed 99.9070 killing. Using 10-fold and loo-fold
dilutions of the antibiotic-containing broth avoids
carry-over of antibiotic, a phenomenon that can
give falsely low MBCs.
The rates of bactericidal activity of 25 I-tg of
amoxicillin/ml against the three strains of strepto-
cocci were determined in trypticase soy broth (Dif-
co Laboratories, Detroit) using 106 organisms
from an overnight culture as the inoculum. A con-
centration of 25 I-tg of amoxicillin/ml was chosen
because it is similar to serum levels achieved in rats
30 min after iv injection of 40 mg of the drug/kg
of body weight and in humans 2 hr after an oral
dose of 3 g [7]. At various times after the inocu-
lation of bacteria into the antibiotic-contain-
ing broth, 10-fold (10-1), 1,000-fold (10-3) , and
100,000-fold (10-5) dilutions of a O.I-ml sample
were subcultured on penicillinase-containing blood
agar plates and incubated overnight before colony
counts were determined.
Serum levels of antibiotics and serum bacte-
2 See footnote 1.
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ricidal activity. Serum levels of antibiotics were
determined by the standard agar diffusion tech-
nique, using Bacillus subtilis as the test organism
and normal rat serum as the diluent [14]. The sam-
ples were taken 30 min and 1, 2, and 4 hr after
administration of various iv doses of amoxicillin
to groups of five rats. The serum bactericidal ac-
tivity against each strain 30 min and 1, 2, and 4 hr
after iv administration of amoxicillin to nine rats
was determined by standard methods [8], using
105 organisms from an overnight culture as the in-
oculum. The serum bactericidal activity was de-
fined as the highest serum dilution providing
99.9070 killing «100 surviving bacteria) after 18 hr
of incubation.
Production of endocarditis and evaluation of
infection. Sterile vegetations were produced in
female Wistar rats (weight, 180-200 g) by a slight
modification of a previously described method
[11]. In brief, a polyethylene catheter (model no.
PP 10; Portex, Hythe, Kent, England) was in-
serted through the aortic valve into the left ventri-
cle via the right carotid artery and secured with a
silk ligature. Twenty-four hours after catheriza-
tion, rats were injected in the tail vein with 0.5 ml
of 0.85070 NaCI containing inocula of various sizes
(expressed in cfu) from overnight cultures of the
test microorganisms. Rats were killed 72 hr there-
after, and 1 ml of blood was drawn from the in-
ferior vena cava and plated on blood agar. Aortic
vegetations were excised, weighed, homogenized
in 1 ml of 0.85070 NaCI, serially diluted, and
plated. Colony counts were determined after 48 hr
of incubation at 37 C. This method permitted the
detection of 102 cfu/g of vegetation.
Prophylaxis of endocarditis with amoxicillin.
Thirty minutes before bacterial challenge with var-
ious inocula of the three test microorganisms,
groups of rats were injected iv with either 40 mg
of amoxicillin/kg of body weight or 0.85070 NaCI
alone.
Influence of amoxicillin on in vitro adhesion of
S. intermedius and S. sanguis to platelet-fibrin
matrices. Experiments were performed using an
in vitro assay system that simulates nonbacterial
thrombotic endocarditis as described by Scheld et
al. [15]. In brief, cultures of S. intermedius or
S. sanguis, grown overnight in brain-heart infu-
sion broth supplemented with 5070 sucrose, were
suspended in either 25 I-tg of amoxicillin/ml
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diluted in phosphate-buffered saline (PBS) or in
PBS alone at a concentration of 103 cfu/ml. These
suspensions were immediately poured into Petri
dishes containing platelet-fibrin matrices, incu-
bated for 2 min at 37 C in a shaking incubator,
and washed two times with amoxicillin or PBS for
5 min and a third time with PBS supplemented
with 2,000 units of penicillinase {Difco)/ml for 5
min. The time of exposure to amoxicillin was
chosen to simulate the mean duration of bacte-
remia after iv challenge [9], during which period
prevention of adhesion has to occur if it is to pre-
vent endocarditis. Penicillinase-containing blood
agar was then poured over the matrices, and the
adherent colonies were counted after 24 hr of in-
cubation. The adherence ratio for each sample
was defined as the number of cfu adherent to the
matrix divided by the initial number of cfu in the
inoculum.
Statistical evaluation. The X2 test with Yates's
correction and Student's unpaired t-test were used
for statistical comparisons.
Results
The MICs and MBCs and the MBC:MIC ratio of
amoxicillin for the three test organisms are shown
in table 1. Although the MBCs of S. intermedius
and S. sanguis were lower when subcultured after
48 hr, both bacteria remained tolerant.
Serum levels of amoxicillin in rats. After iv
administration of various doses of amoxicillin into
rats, it was found that 40 mg/kg iv resulted in a
mean ± so peak serum level of 23.7 ± 3 IJg/ml at
30 min. This level was similar to those achieved in
humans following an oral dose of 3 g of amox-
icillin [7]. The values 1, 2, and 4 hr after iv injec-
tion in the rat were 8.8 ± 1.0 IJg/ml, 3.5 ± 0.4
IJg/ml, and 0.6 ± 0.3 ug/rnl, respectively.
Serum bactericidal activity. In order to
measure the maximum bactericidal activity to
which streptococci were exposed, serum bacterici-
dal activities were measured at the time of bacteri-
al injection, that is, 30 min after iv injection of 40
mg of amoxicillin/kg. No serum bactericidal ac-
tivity could be detected against S. intermedius.
The serum bactericidal activity against S. sanguis
was 1:2, and that against S. mitior was >1:256
(table 1). After 1 hr, no serum bactericidal activity
was detected against either S. intermedius or
S. sanguis, while that against S. mitior was 1:128.
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Serum bactericidal activity of 1:8 against the latter
strain persisted 4 hr after amoxicillin was adminis-
tered iv.
Rate of in vitro killing of the three test strains.
Figure 1 shows the rate of in vitro killing of the
three strains by 25 IJg of amoxicillin/ml, a concen-
tration similar to the serum level achieved in rats
30 min after iv administration of 40 mg/kg and in
humans 2 hr after an oral dose of 3 g. One million
S. mitior organisms/ml were killed in 2 hr. In con-
trast, no significant killing of S. intermedius and
S. sanguis occurred during the first 6 hr of ex-
posure. The rates of killing for the three strains
were similar regardless of whether an overnight or
a log-phase culture was used.
Natural history of experimental endocarditis
and prophylaxis with amoxicillin. S. intermedius
endocarditis. As shown in figure 2, top, the inci-
dence of infection in control rats increased directly
with inoculum size. The 90070 infective dose (1090)
was found to be 105 cfu. In rats that received
amoxicillin prophylaxis and were challenged with
this inoculum, protection was almost complete.
However, in rats receiving larger inocula, the pro-
tective effect of amoxicillin was overcome.
In the animals with endocarditis despite prophy-
laxis with amoxicillin, the mean bacterial densities
in the vegetations were similar to those found in
control animals, suggesting that amoxicillin did
not diminish the severity of endocarditis due to
S. intermedius when it failed to prevent the endo-
cardial infection.
S. sanguis endocarditis. As shown in figure 2,
middle, S. sanguis was less effective in causing en-
docarditis in rats than S. intermedius (1090' 106
cfu). Only in rats challenged with 1 1090 was amox-
icillin fully effective in preventing endocarditis; ef-
ficacy decreased with increasing inoculum size. In
those amoxicillin-treated rats in which endocardi-
tis was produced by giving an inoculum 10 times
higher than the 109o, infection as judged by the
mean bacterial densities in the vegetations was less
severe than in control animals that received no
antibiotic. Thus, unlike the case with S. inter-
medius, amoxicillin influenced not only the inci-
dence but also the course of endocarditis caused
by S. sanguis.
S. mitior endocarditis. In the case of S. mitior,
the 1090 was 105 cfu (figure 2, bottom). In contrast
to both S. intermedius and S. sanguis, S. mitior
failed to produce a high incidence of endocarditis
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in amoxicillin-treated rats, even with inocula 100
or 1,000 times the 1090 • Furthermore, in rats that
developed endocarditis despite prophylaxis, infec-
tion as judged by the mean bacterial densities in
the vegetations was much less severe than that
found in animals that had developed S. sanguis
endocarditis despite prophylaxis (figure 2,
middle).
Effect ofamoxicillin on the in vitro adhesion of
S. intermedius and S. sanguis to platelet-fibrin
matrices. When incubated in vitro with 25 tJg of
amoxicillin/ml for a period of time simulating the
mean duration of bacteremia in vivo [9], the ad-
herence ratio (mean ± so of 12 determinations)
was reduced from 0.0174 ± 0.0055 for control de-
terminations (PBS alone) to 0.0038 ± 0.0009 for
determinations with amoxicillin-incubated S. in-
termedius, a reduction of 78010 (P < 10-5) . For
S. sanguis, the mean adherence ratio fell from
0.0165 ± 0.002 in control determinations to 0.009
± 0.001 for those with amoxicillin-incubated bac-
teria, a reduction of 44010 (P < 10-5) (data not
shown).
Discussion
Previous studies in rabbits have stressed the need
for a bactericidal antibiotic or combination of an-
tibiotics to achieve adequate prophylaxis against
endocarditis due to S. sanguis. It has been ob-
served, however, that vancomycin, the most potent
antibiotic in rabbits, may afford protection in the
absence of bacterial killing both in rabbits and rats
[9, 16]. The present study clarifies the conditions
in which killing or alternative mechanisms may be
operative in preventing endocarditis.
It is improbable that successful prophylaxis
against endocarditis due to S. intermedius or
S. sanguis with a short course of amoxicillin could
have acted through bacterial killing. It took 24 hr
or more for sustained concentrations of amoxicil-
lin that simulate peak serum levels to kill both
strains in vitro. In vivo, these peak concentrations
were transient due to the rapid elimination of
amoxicillin from the rat serum, thus leaving little
time for killing of the infectious inoculum (table
1). In addition, only insignificant serum bacterici-
dal activity was detected at the time of bacterial
challenge following administration of amoxicillin.
Thus, these results extend studies of vancomycin
prophylaxis to additional streptococcal strains and
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Figure 1. Rate of in vitro killing of Streptococcus intermedius, Streptococcus sanguis, and Streptococcus mitior by
25 JIg of amoxicillin/ml (a concentration similar to serum levels in rats 30 min after a single dose [40 mg/kg of body
weight] given iv).
to amoxicillin, which is more practical to adminis-
ter than vancomycin. In these studies amoxicillin
prevented endocarditis in the absence of killing,
probably by inhibiting the adherence of S. sanguis
to the sterile vegetation [9, 16]. Several reports
suggest that nonbactericidal concentrations of
f3-lactam antibiotics, which, like vancomycin, act
on cell-wall synthesis, inhibit the adherence of
bacteria in vitro to platelet-fibrin clots [16-19]. In
the present experiments, amoxicillin at concen-
trations simulating peak serum levels rapidly and
efficiently inhibited the in vitro adherence of both
S. intermedius and S. sanguis on platelet-fibrin
matrices. Therefore, we postulate that a single
dose of amoxicillin may have acted through the
same mechanism as vancomycin in preventing en-
docarditis following challenge with bacteria that
are only minimally sensitive to its bactericidal
action.
In contrast to its effects on S. intermedius and
S. sanguis, we found that the prophylactic activity
of amoxicillin against S. mitior was demonstrable
with inoculum sizes that were 1,000 times the ID 9o.
This difference in ability of bacteria to produce
endocarditis after exposure to prophylaxis with
amoxicillin may be related to the different kinetics
of killing among the strains. Only S. mitior was
exposed to a high serum bactericidal activity
(> 1:256) after iv administration of amoxicillin.
Furthermore, S. mitior was the only streptococcal
species of the three tested that was exposed in vivo
to concentrations of amoxicillin greater than its
MBC for a longer period than was required to kill
it in vitro (table 1). We interpret these findings as
indicating that amoxicillin could have acted by
two mechanisms when preventing endocarditis. (1)
With S. mitior, an organism that was rapidly killed,
amoxicillin may have protected primarily by kill-
ing. The protection afforded by killing was
inoculum-independent, that is, not limited to the
ID9o, but extending to inoculum sizes that were
1,000-fold greater. (2) With those strains that were
only slowly killed by amoxicillin in vitro, protec-
tion may have been due to the prevention of bacte-
rial adherence to vegetations rather than to actual
bacteridical activity [9, 15-19]. Protection af-
forded by this mechanism was inoculum-depen-
dent, that is, limited to the ID90 and decreasing
with increasing inoculum sizes (table 1).
When inoculum sizes of S. mitior 10, 100, or
1,000 times larger than the ID90 were used to infect
rats, the endocardial infection that developed in a
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few rats three days after amoxicillin prophylaxis
was less severe than in control rats. A similar phe-
nomenon, although less pronounced, was ob-
served following challenge with 10 times the ID90
of S. sanguis. Thus, bacteria that were not killed
by amoxicillin appeared damaged sufficiently to
adversely affect multiplication once endocardial
infection was established, thus demonstrating a
postantibiotic effect in vivo [20]. Further experi-
ments have shown that this phenomenon is trans-
ient, since the few rats challenged with S. mitior
that developed endocarditis despite prophylaxis
had 109 cfu of S. mitior/g of vegetation when
killed seven days after infection, a degree of infec-
tion similar to that found in control rats (data not
shown).
The results of this study agree with those of our
recent work showing that a short course of clinda-
mycin prophylaxis successfully prevented endo-
carditis due to S. sanguis, S. intermedius, and
S. mitior in rats when given in doses that produce
serum levels equal to those achievable by oral
administration in humans [21]. Since clindamycin
is bacteriostatic, these experiments provide further
evidence that killing is not essential for effective
prophylaxis. The results of both studies appear to
contradict those of previous observations in rab-
bits by Durack and Petersdorf [5] and Pelletier et
at. [12], in which single injections of several anti-
biotics failed to prevent infection. However, the
latter experiments were performed with an in-
oculum of 108 cfu of S. sanguis, an inoculum
which was probably many times higher than the
ID90 for rabbits. If so, our observations on the
dependence of prophylaxis efficacy on inoculum
size provides an explanation for this apparent
Figure 2. Incidence of endocarditis in control and
amoxicillin-treated rats three days after bacterial
challenge with (top) Streptococcus intermedius, (mid-
dle) Streptococcus sanguis, and (bottom) Streptococcus
mitior. The mean (± SD) bacterial density (MBD)
recovered from vegetations (expressed as cfu/g of
vegetation) is indicated for each group. The no. of rats
with infected vegetations/total no. of rats per group is
indicated at the base of each column. To compare the
incidence of endocarditis in control vs. treated rats, P
valueswerecalculated by Xlanalysiswith Yates'scorrec-
tion. To compare MBDs in control vs. treated rats
challenged with the same inoculum size, P values were
calculated by Student's unpaired t-test (n.s. = not
significant).
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contradiction. Rabbits challenged with many
times the IDgo would not be protected because the
strain of S. sanguis used in these studies (provided
to us by Dr. Durack) was not rapidly killed by the
antibiotics tested for prophylaxis.
In considering the relevance of these results to
prophylaxis against endocarditis in humans, we
were interested to know which of the two prophy-
lactic mechanisms we have observed was likely to
be clinically operative. We found that one-third of
streptococcal strains causing endocarditis were
tolerant to amoxicillin and two-thirds were toler-
ant to vancomycin." This result suggests that, to
prevent bacterial endocarditis due to these tolerant
strains, these antibiotics would have to act by
mechanisms other than killing. The present experi-
ments in rats indicate that these alternative mech-
anisms protect against challenging inocula only as
high as the ID go• However, there are two reasons
which suggest that the administration of 3 g of
amoxicillin could prevent endocarditis in humans.
(1) The magnitude of the bacteremia necessary to
reach the IDgo in rats is probably far greater than
that present in humans after dental manipulation
[22]. (2) In the present experiments, the plastic
catheter was left in place before prophylaxis was
tested; however, few patients at risk of developing
endocarditis harbor an endovascular foreign
body, and we have previously shown that removal
of the catheter increases the effectiveness of pro-
phylaxis with vancomycin 1,000-fold [11]. The
results in our experimental model therefore sug-
gest that, even in the absence of bacterial killing,
endocarditis may be prevented by other mecha-
nisms- possibly inhibition of adherence - and
that these mechanisms may give the prophylactic
regimen a margin of safety even after single-dose
prophylaxis.
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